Singhirunnusorn, P., Moolmuang, B., Lirdprapamongkol, K., & Ruchirawat, M. (2018). Arsenite exposure potentiates apoptosis-inducing effects of tumor necrosis factor-alpha- through reactive oxygen species. J Toxicol Sci, 43(2), 159-169. doi:10.2131/jts.43.159

27 Dec 2018
0
0

Singhirunnusorn, P., Moolmuang, B., Lirdprapamongkol, K., & Ruchirawat, M. (2018). Arsenite exposure potentiates apoptosis-inducing effects of tumor necrosis factor-alpha- through reactive oxygen species. J Toxicol Sci, 43(2), 159-169. doi:10.2131/jts.43.159

Tags

Share this

Related Posts

A possible pitfall in the identification of Burkholderia mallei using molecular identification systems based on the sequence of the flagellin fliC gene. Sprague LD, Zysk G, Hagen RM, Meyer H, Ellis J, Anuntagool N, Gauthier Y, Neubauer H FEMS Immunol Med Microbiol34p231-6(2002 Nov 15)
15 Nov 2002
0

A possible pitfall in the identification of Burkholderia mallei using molecular identification systems based on the sequence of the flagellin fliC gene. Sprague LD, Zysk G, Hagen RM, Meyer H, Ellis J, Anuntagool N, Gauthier Y, Neubauer H FEMS Immunol Med Microbiol34p231-6(2002 Nov 15)

A possible pitfall in the identification of Burkholderia mallei using molecular identification systems based on the sequence of the flagellin fliC gene. Sprague LD, Zysk G, Hagen RM, Meyer H, Ellis J, Anuntagool N, Gauthier Y, Neubauer H FEMS Immunol Med Microbiol34p231-6(2002 Nov 15)
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
New
20 Sep 2023
0
New

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More